|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gastrointestinal cancer
First-in-Human Phase 1 Study of a B Cell– and Monocyte-Based Immuno
therapeutic
Vaccine against HER2-Positive Advanced Gastric Cancer
Minkyu Jung, Jii Bum Lee, Hyo Song Kim, Woo Sun Kwon, Hyun Ok Kim, Sinyoung Kim, Myunghwan Park, Wuhyun Kim, Ki-Young Choi, Taegwon Oh, Chang-Yuil Kang, Hyun Cheol Chung, Sun Young Rha
Cancer Res Treat.
2024;56(1):208-218. Published online June 28, 2023 DOI:
https://doi.org/10.4143/crt.2022.1328
Web of Science 1
Crossref 1
Breast cancer
Health-Seeking Behavior Returning to Normalcy Overcoming COVID-19 Threat in Breast Cancer
Eun-Gyeong Lee, Yireh Han, Dong-Eun Lee, Hyeong-Gon Moon, Hyoung Won Koh, Eun-Kyu Kim, So-Youn Jung
Cancer Res Treat.
2023;55(4):1222-1230. Published online April 3, 2023 DOI:
https://doi.org/10.4143/crt.2023.364
Gastrointestinal cancer
First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017
Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sang-Jae Park, Young-Joo Won, Sun-Whe Kim
Cancer Res Treat.
2022;54(1):208-217. Published online May 21, 2021 DOI:
https://doi.org/10.4143/crt.2021.421
Web of Science 9
Crossref 9
Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
Ah-Rong Nam, Ji-Won Kim, Ji Eun Park, Ju-Hee Bang, Mei Hua Jin, Do-Youn Oh, Yung-Jue Bang
Cancer Res Treat.
2019;51(3):886-900. Published online October 1, 2018 DOI:
https://doi.org/10.4143/crt.2018.375
Web of Science 5
Crossref 3
Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su
Cancer Res Treat.
2018;50(2):530-537. Published online June 1, 2017 DOI:
https://doi.org/10.4143/crt.2017.156
Web of Science 22
Crossref 22
A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer
Cancer Res Treat.
2016;48(3):1120-1129. Published online February 12, 2016 DOI:
https://doi.org/10.4143/crt.2015.436
Web of Science 8
Crossref 8
Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
Dongryul Oh, Sung Wook Shin, Hee Chul Park, Sung Ki Cho, Do Hoon Lim, Seung Woon Paik
Cancer Res Treat.
2015;47(2):251-258. Published online October 27, 2014 DOI:
https://doi.org/10.4143/crt.2014.011
Web of Science 14
Crossref 12
Therapeutic
Outcome and Prognosis in Dlderly Patients with Non - Hodgkin's Lymphoma
Jee Sook Hahn, Jin Hyuk Choi, Seung Tae Lee, Yoo Hong Min, Yun Woong Ko
J Korean Cancer Assoc.
1999;31(2):320-330.
Clinical Trial of Human Recombinant Interleukin-2 ( IL-2
Joung Soon Jang, Jae Bum Jun, Joon Soo Hahm, Min Ho Lee, Il Young Choi, Te June Chung
J Korean Cancer Assoc.
1990;22(1):96-106.
Association of Immune-Related Adverse Events and the Efficacy of Anti-PD-(L)1 Monotherapy in Non-Small Cell Lung Cancer: Adjusting for Immortal-Time Bias
Ying Yu, Ning Chen, Sizhe Yu, Wanji Shen, Wanchen Zhai, Hui Li, Yun Fan
Received October 11, 2023 Accepted December 30, 2023 Published online January 2, 2024
DOI:
https://doi.org/10.4143/crt.2023.1118
[Accepted]
1
Journal Impact Factor 4.6